News
Dow Jumps Over 400 Points; US Adds 175,000 Jobs In April
3 May 24
Earnings, Equities, News, Eurozone, Commodities, Intraday Update, Markets, Trading Ideas
12 Health Care Stocks Moving In Friday's Pre-Market Session
3 May 24
Movers
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
3 May 24
News, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Intraday Session
30 Apr 24
Movers
12 Health Care Stocks Moving In Monday's After-Market Session
29 Apr 24
Movers
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
24 Apr 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
24 Apr 24
Movers
Why Vaxxinity (VAXX) Shares Are Volatile Today
23 Apr 24
News
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
22 Apr 24
News, Eurozone, Commodities, Intraday Update, Markets, Trading Ideas
Why Vaxxinity (VAXX) Shares Are Down Nearly 50%
22 Apr 24
News
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
22 Apr 24
News, Intraday Update, Markets, Movers
Why Riot Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
22 Apr 24
News, Pre-Market Outlook, Markets, Movers
12 Health Care Stocks Moving In Friday's After-Market Session
19 Apr 24
Movers
Vaxxinity Q4 EPS $(0.09) Beats $(0.10) Estimate
27 Mar 24
Earnings, News
12 Health Care Stocks Moving In Monday's After-Market Session
25 Mar 24
Movers
Vaxxinity Announces Target Engagement Data From Phase 1 Clinical Trial For Parkinson's Disease At AD/PD 2024
7 Mar 24
Biotech, News, Events, General
Press releases
Vaxxinity Issues Shareholder Letter
19 Apr 24
Press Releases
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
19 Apr 24
Markets, Press Releases
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
28 Mar 24
News, Press Releases
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
27 Mar 24
Earnings, Press Releases
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson's Disease at AD/PD™ 2024
7 Mar 24
News, Press Releases